Bristol's $1 bln Bavarian deal may signal cancer vaccine revival
March 04, 2015 at 10:37 AM EST
LONDON, March 4 (Reuters) - The idea of using vaccines to fight cancer has received a shot in the arm from a $1 billion deal between Bristol-Myers Squibb and Bavarian Nordic .
